2016 Q3 Form 10-Q Financial Statement

#000156459016027390 Filed on November 03, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q4 2015 Q3
Revenue $38.00K $226.0K $133.0K
YoY Change -71.43% -75.8% -66.75%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.400M $2.370M $2.420M
YoY Change -0.83% 10.75% 52.2%
% of Gross Profit
Research & Development $11.17M $8.950M $6.574M
YoY Change 69.91% 63.92% 62.84%
% of Gross Profit
Depreciation & Amortization $70.00K $140.0K $110.0K
YoY Change -36.36% -22.22% -52.17%
% of Gross Profit
Operating Expenses $13.57M $11.32M $9.574M
YoY Change 41.74% 48.95% 61.72%
Operating Profit -$13.53M -$11.09M -$9.441M
YoY Change 43.29% 66.32% 71.03%
Interest Expense $20.00K $20.00K $4.000K
YoY Change 400.0% -105.0% -112.12%
% of Operating Profit
Other Income/Expense, Net $2.000K $10.00K -$1.000K
YoY Change -300.0% -101.54% -96.0%
Pretax Income -$13.51M -$11.06M -$9.822M
YoY Change 37.55% 43.26% 67.33%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.993M -$3.169M -$4.103M
YoY Change -2.68% -58.92% -30.1%
Net Earnings / Revenue -10507.89% -1402.21% -3084.96%
Basic Earnings Per Share
Diluted Earnings Per Share -$411.8K -$345.3K -$493.4K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.10M $88.00M $97.00M
YoY Change -47.32% 6185.71%
Cash & Equivalents $51.06M $88.00M $97.01M
Short-Term Investments
Other Short-Term Assets $1.100M $1.100M $800.0K
YoY Change 37.5% 450.0%
Inventory
Prepaid Expenses
Receivables $0.00 $69.00K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $52.10M $89.19M $97.81M
YoY Change -46.73% 5436.06%
LONG-TERM ASSETS
Property, Plant & Equipment $500.0K $624.0K $669.0K
YoY Change -25.26% -83.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.100M $1.722M $1.669M
YoY Change 25.82% 1465.45%
Total Long-Term Assets $2.600M $2.346M $2.386M
YoY Change 8.97% -79.31%
TOTAL ASSETS
Total Short-Term Assets $52.10M $89.19M $97.81M
Total Long-Term Assets $2.600M $2.346M $2.386M
Total Assets $54.70M $91.53M $100.2M
YoY Change -45.41% 606.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.60M $3.262M $5.800M
YoY Change 82.76% 59.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $10.60M $7.726M $6.076M
YoY Change 74.46% 12.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $200.0K $245.0K $53.00K
YoY Change 277.36% -94.47%
Total Long-Term Liabilities $200.0K $245.0K $53.00K
YoY Change 277.36% -96.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.60M $7.726M $6.076M
Total Long-Term Liabilities $200.0K $245.0K $53.00K
Total Liabilities $166.0M $7.971M $6.129M
YoY Change 2608.44% -89.18%
SHAREHOLDERS EQUITY
Retained Earnings -$196.0M -$211.6M
YoY Change
Common Stock $117.7M $117.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$111.2M -$77.97M -$94.19M
YoY Change
Total Liabilities & Shareholders Equity $54.70M $91.53M $100.2M
YoY Change -45.41% 606.76%

Cashflow Statement

Concept 2016 Q3 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$3.993M -$3.169M -$4.103M
YoY Change -2.68% -58.92% -30.1%
Depreciation, Depletion And Amortization $70.00K $140.0K $110.0K
YoY Change -36.36% -22.22% -52.17%
Cash From Operating Activities -$12.72M -$8.970M -$9.830M
YoY Change 29.4% 28.51% 76.8%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$60.00K -$10.00K
YoY Change -100.0% -700.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $30.00K
YoY Change -84.21%
Cash From Investing Activities $0.00 -$40.00K -$10.00K
YoY Change -100.0% -120.0% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K 0.000 104.4M
YoY Change -100.06% -100.0% 2005.65%
NET CHANGE
Cash From Operating Activities -12.72M -8.970M -9.830M
Cash From Investing Activities 0.000 -40.00K -10.00K
Cash From Financing Activities -60.00K 0.000 104.4M
Net Change In Cash -12.78M -9.010M 94.60M
YoY Change -113.51% -2750.0% -15608.2%
FREE CASH FLOW
Cash From Operating Activities -$12.72M -$8.970M -$9.830M
Capital Expenditures $0.00 -$60.00K -$10.00K
Free Cash Flow -$12.72M -$8.910M -$9.820M
YoY Change 29.53% 27.47% 76.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Profit Loss
ProfitLoss
-41642000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
50000
us-gaap Profit Loss
ProfitLoss
-30048000
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5719000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-29340000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-3993000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88003000
vtvt Research And Development Expense Related Party
ResearchAndDevelopmentExpenseRelatedParty
1532000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1988000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-851000
CY2015Q3 vtvt Other Income Expenses Related Party
OtherIncomeExpensesRelatedParty
-56000
vtvt Other Income Expenses Related Party
OtherIncomeExpensesRelatedParty
-392000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
63000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-86000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
1667000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41642000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30048000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5719000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-4103000
us-gaap Net Income Loss
NetIncomeLoss
-12302000
us-gaap Net Income Loss
NetIncomeLoss
-24329000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3164000
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-26120000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000
us-gaap Depreciation
Depreciation
216000
us-gaap Depreciation
Depreciation
361000
us-gaap Share Based Compensation
ShareBasedCompensation
1988000
us-gaap Share Based Compensation
ShareBasedCompensation
304000
vtvt Change In Fair Value Of Contingent Distribution
ChangeInFairValueOfContingentDistribution
695000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
27000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
48000
vtvt Bad Debt Expense Recovery Related Party
BadDebtExpenseRecoveryRelatedParty
-2000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-56000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
705000
us-gaap Increase Decrease In Due From Employee Current
IncreaseDecreaseInDueFromEmployeeCurrent
-46000
us-gaap Increase Decrease In Due From Employee Current
IncreaseDecreaseInDueFromEmployeeCurrent
-12000
us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
20000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
268000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1594000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3417000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1544000
vtvt Increase Decrease In Accounts Payable And Accrued Liabilities Related Parties
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParties
-474000
vtvt Increase Decrease In Accounts Payable And Accrued Liabilities Related Parties
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParties
2094000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-198000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
320000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1012000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-36783000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-27976000
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
4000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-83000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-42000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
105773000
vtvt Payment Of Offering Cost Related Party
PaymentOfOfferingCostRelatedParty
1329000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19289000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
29000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
89000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-79000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
123644000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-36945000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
95626000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1384000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97010000
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
2746000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
3164000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, the Company evaluates its estimates, including those related to the grant date fair value of equity awards, the fair value of the Class B Common Stock, the useful lives of property and equipment, the fair value of the Company&#8217;s membership units, the fair value of redeemable preferred units, the fair value of derivative liabilities, and the fair value of the Company&#8217;s debt, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p></div>
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1058821
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P9Y
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.31
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions. The balances of these cash accounts frequently exceed insured limits.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no accounts receivable balances outstanding as of September&#160;30, 2016.&nbsp;&nbsp;Accounts receivable at December&#160;31, 2015 were $0.1 million with one customer representing 100% of this balance.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">One and two customers represented 100% of the revenue earned during the three and nine months ended September&#160;30, 2016.&nbsp;&nbsp;One customer represented 100% of the revenue during the three and nine months ended September&#160;30, 2015.</p></div>
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5000000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.94
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.05
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
971934
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
129500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1099434
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
287825
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.80
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.22
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.67
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.97
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
10.73
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
681000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
304000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1988000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
304000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of Class A Common Stock and Class B Common Stock are entitled to one vote for each share held on all matters submitted to stockholders for their vote or approval.
CY2016Q3 vtvt Redeemable Noncontrolling Interest Temporary Equity Redemption Value
RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue
155100000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
vtvt Percentage Of Amount Of Cash Savings
PercentageOfAmountOfCashSavings
0.85

Files In Submission

Name View Source Status
0001564590-16-027390-index-headers.html Edgar Link pending
0001564590-16-027390-index.html Edgar Link pending
0001564590-16-027390.txt Edgar Link pending
0001564590-16-027390-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2016110219252878310537.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtvt-10q_20160930.htm Edgar Link pending
vtvt-20160930.xml Edgar Link completed
vtvt-20160930.xsd Edgar Link pending
vtvt-20160930_cal.xml Edgar Link unprocessable
vtvt-20160930_def.xml Edgar Link unprocessable
vtvt-20160930_lab.xml Edgar Link unprocessable
vtvt-20160930_pre.xml Edgar Link unprocessable
vtvt-ex311_8.htm Edgar Link pending
vtvt-ex312_6.htm Edgar Link pending
vtvt-ex321_9.htm Edgar Link pending
vtvt-ex322_7.htm Edgar Link pending